Thrombelastography compared with multiple impedance aggregometry to assess high on-clopidogrel reactivity in patients with atrial fibrillation undergoing percutaneous coronary intervention

• Verfasst von: Gjermeni, Diona [VerfasserIn]
• Verfasst von: Vetter, Hannah [VerfasserIn]
• Verfasst von: Szabó, Sofia [VerfasserIn]
• Verfasst von: Anfang, Viktoria [VerfasserIn]
• Verfasst von: Leggewie, Stefan [VerfasserIn]
• Verfasst von: Hesselbarth, David [VerfasserIn]
• Verfasst von: Dürschmied, Daniel [VerfasserIn]
• Verfasst von: Trenk, Dietmar [VerfasserIn]
• Verfasst von: Olivier, Christoph [VerfasserIn]
• Titel: Thrombelastography compared with multiple impedance aggregometry to assess high on-clopidogrel reactivity in patients with atrial fibrillation undergoing percutaneous coronary intervention
• Verf.angabe: Diona Gjermeni, Hannah Vetter, Sofia Szabó, Viktoria Anfang, Stefan Leggewie, David Hesselbarth, Daniel Duerschmied, Dietmar Trenk and Christoph B. Olivier
• E-Jahr: 2022
• Jahr: 21 July 2022
• Umfang: 10 S.
• Fussnoten: Dieser Artikel gehört zum Special issue: Clinical research on viscoelastic testing ; Gesehen am 21.11.2023
• Titel Quelle: Enthalten in: Journal of Clinical Medicine
• Ort Quelle: Basel : MDPI, 2012
• Jahr Quelle: 2022
• Band/Heft Quelle: 11(2022), 14, Artikel-ID 4237, Seite 1-10
• ISSN Quelle: 2077-0383
• DOI: doi:10.3390/jcm11144237
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: atrial fibrillation
• Sach-SW: multiple electrode aggregometry
• Sach-SW: percutaneous coronary intervention
• Sach-SW: platelet reactivity
• Sach-SW: thrombelastography
• K10plus-PPN: 1870759958

Abstract

Background: High on-clopidogrel platelet reactivity (HPR) following percutaneous coronary intervention (PCI) is associated with increased ischemic risk. It is unclear whether conventional definitions of HPR apply to patients with concomitant oral anticoagulation (OAC). This study aimed to compare the performance of multiple platelet aggregometry (MEA) and thrombelastography (TEG) to detect HPR in patients with atrial fibrillation (AF) and indication for an OAC. Methods: In this observational single-center cohort study, MEA and TEG were performed in patients with AF with an indication for OAC on day 1 to 3 after PCI. The primary outcome was HPR as assessed by MEA (ADP area under the curve ≥ 46 units [U]) or TEG (MAADP ≥ 47 mm), respectively. The secondary exploratory outcomes were a composite of all-cause death, myocardial infarction (MI) or stroke and bleeding, as defined by the International Society on Thrombosis and Hemostasis, at 6 months. Results: Platelet function of 39 patients was analyzed. The median age was 78 (interquartile range [IQR] was 72-82) years. 25 (64%) patients were male, and 19 (49%) presented with acute coronary syndrome. All patients received acetylsalicylic acid and clopidogrel prior to PCI. Median (IQR) ADP-induced aggregation, MAADP, TRAP-induced aggregation, and MAthrombin were 9 (6-15) U, 50 (43-60) mm, 54 (35-77) U and 65 (60-67) mm, respectively. The rate of HPR was significantly higher if assessed by TEG compared with MEA (25 [64%] vs. 1 [3%]; p < 0.001). Within 6 months, four (10%) deaths, one (3%) MI and nine (23%) bleeding events occurred. Conclusion: In patients with AF undergoing PCI, the rates of HPR detected by TEG were significantly higher compared with MEA. Conventional cut-off values for HPR as proposed by consensus documents may need to be re-evaluated for this population at high ischemic and bleeding risk. Further studies are needed to assess the association with outcomes.